Tech Company Financing Transactions
Claritas Genomics Funding Round
Claritas Genomics secured a $15 million Series B venture capital round on 1/28/2015. Investors included WuXi PharmaTech, Boston Children's Hospital and Cerner.
Transaction Overview
Company Name
Announced On
1/28/2015
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
WuXi PharmaTech (Lead Investor) (Hannes Smarason)
Proceeds Purpose
Proceeds will be used to expand its commercial operations, launch new next generation sequencing-based tests for diagnosis of pediatric genetic disorders and continue to build its network of clinical pediatric disease experts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
99 Erie St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
At Claritas, we believe that now is the time to integrate genomics into clinical practice. Our mission is to make that happen.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrice Milos
Chief Financial Officer
Darlene Deptula-Hicks
Chief Operating Officer
Mary Cortizas
Chief Technical Officer
John Thompson
VP - Bus. Development
Nurjana Bachman
VP - Bus. Development
Patrick Terry
Browse more venture capital transactions:
Prev: 1/28/2015: Anews venture capital transaction
Next: 1/28/2015: Engage.cx venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs